Business description
Zealand Pharma A/S is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial partnerships for its marketed products.
Management board & Supervisory board
| CEO |
| Adam Steensberg |
| Management board |
| Henriette Wennicke, David Kendall, Ivan Møller, Christina Sonnenborg Bredal , Ravinder Chahil |
| Supervisory board |
| Martin Nicklasson, Kirsten A. Drejer, Jeffrey Berkowitz, Bernadette Connaughton, Leonard Kruimer, Alain Munoz, Michael John Owen, Frederik Barfoed Beck, Anneline Nansen, Louise Gjelstrup, Jens Peter Stenvang, Enrique Conterno, Elaine Sullivan |
Company data
| Name: |
Zealand Pharma A/S |
| Address: |
Sydmarken 11,2860 Søborg |
| Phone: |
- |
| Fax: |
- |
| E-mail: |
+45 88 77 36 00
|
| Internet: |
info@zealandpharma.com |
| Industry: |
Biotechnology |
| Sector: |
Biotechnology |
| Sub sector: |
- |
| End of financial year: |
31/12 |
| Free Float: |
- |
| IPO date: |
- |
